Promising efficacy and safety of feladilimab in recurrent/metastatic urothelial carcinoma Presented ByDr Arjun Balar , Perlmutter Cancer Center, NY, USA TrialPhase 1, INDUCE-1 ConferenceASCO 2021 TypePeer-reviewed article 12 August 2021 12:30